Cargando…

Human urinary kallidinogenase combined with edaravone in treating acute ischemic stroke patients: A meta‐analysis

INTRODUCTION: Several studies have investigated the efficacy of human urinary kallidinogenase (HUK) combined with edaravone (Eda) in acute ischemic stroke (AIS) patients. Our aim was to provide the best available evidence for clinical practice and further research programs for stroke treatment. METH...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Di‐Xiao, Li, Yao, Yu, Dan, Guan, Bi, Ming, Qian, Li, Yan, Chen, Li‐Qing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671773/ https://www.ncbi.nlm.nih.gov/pubmed/34808033 http://dx.doi.org/10.1002/brb3.2431

Ejemplares similares

Human urinary kallidinogenase or edaravone combined with butylphthalide in the treatment of acute ischemic stroke
por: Qian, Yun, et al.
Publicado: (2019)

Analysis of treatment effect of urinary kallidinogenase combined with edaravone on massive cerebral infarction
por: Ke, Jiang, et al.
Publicado: (2016)

Efficacy and safety of human urinary kallidinogenase for acute ischemic stroke: a meta-analysis
por: Huang, Yuanxiang, et al.
Publicado: (2020)

Treatment of Human Urinary Kallidinogenase Combined with Maixuekang Capsule Promotes Good Functional Outcome in Ischemic Stroke
por: Song, Juexian, et al.
Publicado: (2018)

Human urinary kallidinogenase in acute ischemic stroke: A single‐arm, multicenter, phase IV study (RESK study)
por: Ni, Jun, et al.
Publicado: (2021)

Human Urinary Kallidinogenase Promotes Angiogenesis and Cerebral Perfusion in Experimental Stroke
por: Han, Lijuan, et al.
Publicado: (2015)

Exogenous human urinary kallidinogenase increases cerebral blood flow in patients with acute ischemic stroke
por: Miao, Jing, et al.
Publicado: (2016)

Human Urinary kallidinogenase promotes good recovery in ischemic stroke patients with level 3 hypertension
por: Wu, Danhong, et al.
Publicado: (2017)

Therapeutic Values of Human Urinary Kallidinogenase on Cerebrovascular Diseases
por: Wei, Zhenyu, et al.
Publicado: (2018)

Urinary kallidinogenase for the treatment of cerebral arterial stenosis
por: Zhao, Liandong, et al.
Publicado: (2015)

Clinical efficacy analysis of butylphthalide combined with urinary kallidinogenase in treating chronic cerebral circulatory insufficiency
por: Hu, Bo, et al.
Publicado: (2023)

Human urinary kallidinogenase may improve the prognosis of acute stroke patients with early neurological deterioration
por: Xie, Yiju, et al.
Publicado: (2022)

Urinary Kallidinogenase plus rt-PA Intravenous Thrombolysis for Acute Ischemic Stroke: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Wu, Jing, et al.
Publicado: (2022)

The Combination of Human Urinary Kallidinogenase and Mild Hypothermia Protects Adult Rats Against Hypoxic-Ischemic Encephalopathy-Induced Injury by Promoting Angiogenesis and Regeneration
por: Gao, Xiaoya, et al.
Publicado: (2018)

Human Urinary Kallidinogenase decreases recurrence risk and promotes good recovery
por: Han, Dong, et al.
Publicado: (2018)

Retracted: Urinary Kallidinogenase plus rt-PA Intravenous Thrombolysis for Acute Ischemic Stroke: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Efficacy of Butylphthalide in Combination with Edaravone in the Treatment of Acute Ischemic Stroke and the Effect on Serum Inflammatory Factors
por: Li, Yan, et al.
Publicado: (2023)

Efficacy of Urinary Kallidinogenase Plus Intravenous Recombinant Tissue Plasminogen Activator for Stroke Patients With Extended Window: A Retrospective Analysis
por: Li, Xueyuan, et al.
Publicado: (2023)

Effect of Urinary Kallidinogenase on Transforming Growth Factor-β(1) and High-Sensitivity C-Reactive Protein Expression in Rat Focal Cerebral Ischemic Injury
por: Dong, Ting-Fang, et al.
Publicado: (2016)

Cost-effectiveness of edaravone dexborneol versus edaravone for the treatment of acute ischemic stroke in China: Based on the TASTE study
por: Shi, Fenghao, et al.
Publicado: (2022)

Edaravone and cyclosporine A as neuroprotective agents for acute ischemic stroke
por: Matsumoto, Shohei, et al.
Publicado: (2018)

Effects of Urinary Kallidinogenase on NIHSS score, mRS score, and fasting glucose levels in acute ischemic stroke patients with abnormal glucose metabolism: A prospective cohort study
por: Chen, Lei, et al.
Publicado: (2019)

Edaravone combined with Shuxuening versus edaravone alone in the treatment of acute cerebral infarction: A systematic review and meta-analysis
por: Li, Liang-Da, et al.
Publicado: (2023)

Human Urinary Kallidinogenase Reduces Lipopolysaccharide-Induced Neuroinflammation and Oxidative Stress in BV-2 Cells
por: Zhao, Zhongyan, et al.
Publicado: (2019)

A novel brain targeted plasma exosomes enhance the neuroprotective efficacy of edaravone in ischemic stroke
por: Guo, Lin, et al.
Publicado: (2021)

How is edaravone effective against acute ischemic stroke and amyotrophic lateral sclerosis?
por: Watanabe, Kazutoshi, et al.
Publicado: (2018)

Synergy of Combined tPA-Edaravone Therapy in Experimental Thrombotic Stroke
por: Sun, Yu-Yo, et al.
Publicado: (2014)

Efficacy and safety of blood-activating herbs combined with edaravone in the treatment of acute ischemic stroke: A protocol for systematic review and meta-analysis
por: Su, Zhuoyi, et al.
Publicado: (2022)

Effects of Butylphthalide Sodium Chloride Injection Combined with Edaravone Dexborneol on Neurological Function and Serum Inflammatory Factor Levels in Sufferers Having Acute Ischemic Stroke
por: Li, Keliang, et al.
Publicado: (2022)

A randomized controlled clinical trial to compare the safety and efficacy of edaravone in acute ischemic stroke
por: Sharma, Pawan, et al.
Publicado: (2011)

Edaravone Dexborneol Downregulates Neutrophil Extracellular Trap Expression and Ameliorates Blood-Brain Barrier Permeability in Acute Ischemic Stroke
por: Huang, Yuanxiang, et al.
Publicado: (2022)

Free radical scavenger, edaravone, reduces the lesion size of lacunar infarction in human brain ischemic stroke
por: Nakase, Taizen, et al.
Publicado: (2011)

Edaravone-Encapsulated Agonistic Micelles Rescue Ischemic Brain Tissue by Tuning Blood-Brain Barrier Permeability
por: Jin, Qu, et al.
Publicado: (2017)

Effects of Edaravone on Muscle Atrophy and Locomotor Function in Patients with Ischemic Stroke: A Randomized Controlled Pilot Study
por: Naritomi, Hiroaki, et al.
Publicado: (2012)

Clinical effects and safety of edaravone in treatment of acute ischaemic stroke: A meta‐analysis of randomized controlled trials
por: Chen, Chongyue, et al.
Publicado: (2021)

Edaravone combined with Schwann cell transplantation may repair spinal cord injury in rats
por: Zhang, Shu-quan, et al.
Publicado: (2015)

Edaravone Enhances Brain-Derived Neurotrophic Factor Production in the Ischemic Mouse Brain
por: Okuyama, Satoshi, et al.
Publicado: (2015)

Retracted: Effects of Butylphthalide Sodium Chloride Injection Combined with Edaravone Dexborneol on Neurological Function and Serum Inflammatory Factor Levels in Sufferers Having Acute Ischemic Stroke
por: Healthcare Engineering, Journal of
Publicado: (2023)

Clinical efficacy of tirofiban combined with a Solitaire stent in treating acute ischemic stroke
por: Zhang, Yang, et al.
Publicado: (2019)

Edaravone promotes functional recovery after mechanical peripheral nerve injury
por: Zhang, Teng, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_pjagvrj5ag8im0nn5hbu1goilo